Press Releases
Aptamer Group signs deal with Flip Gene Therapeutics to support the development of inducible gene therapies
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, has negotiated a deal with the biotechnology...
Press Releases
Achema 2022: Syntegon showcases new solutions for process development and manufacturing of solid pharmaceuticals
At this year’s Achema in Frankfurt, Syntegon is presenting new solutions for the production of solid pharmaceutical dosage forms. With the fluid bed laboratory...
News
The IMA Group on show at INTERPHEX NY 2022
From 24 to 26 May, the pharmaceutical divisions of the IMA Group are gathering up in New York at Interphex 2022 - Booth...
Press Releases
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision...
Press Releases
CPHI China opens for international partnering after China rises in CPHI Index
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see...
News
Cugene And Proteros Offer Value For AbbVie And AstraZeneca
Smaller biotech startups with promising technology platforms frequently collaborate with larger biopharma companies. Cugene and AbbVie on inflammatory illnesses and cancer, and Proteros and...
Industry Reports
Pfizer Shells Out $11.6 Bn. For Biohaven- Largest Since 2016
Pfizer will pay $11.6 billion for migraine medicine manufacturer Biohaven Pharmaceutical, signifying the company's largest acquisition since 2016, as it seeks to expand its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read